These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22229256)

  • 21. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
    Kang JL; Wang XX; Nie ML; Huang XH
    Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Howell R; Edmonds DK; Dowsett M; Crook D; Lees B; Stevenson JC
    Fertil Steril; 1995 Sep; 64(3):474-81. PubMed ID: 7641897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
    Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
    Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
    Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
    J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF.
    Cantor A; Tannus S; Son WY; Tan SL; Dahan MH
    Reprod Biomed Online; 2019 Apr; 38(4):520-527. PubMed ID: 30935663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
    Bedaiwy MA; Mousa NA; Casper RF
    Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis.
    Vercellini P; Crosignani PG; Fadini R; Radici E; Belloni C; Sismondi P
    Br J Obstet Gynaecol; 1999 Jul; 106(7):672-7. PubMed ID: 10428523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
    Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
    Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging use of aromatase inhibitors for endometriosis treatment.
    Nothnick WB
    Reprod Biol Endocrinol; 2011 Jun; 9():87. PubMed ID: 21693036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
    Chen JM; Gao HY; Ding Y; Yuan X; Wang Q; Li Q; Jiang GH
    Chin Med J (Engl); 2015 Feb; 128(4):427-32. PubMed ID: 25673440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Materials on the novel preparation Zoladex. 1 March 1995, Moscow, Russia].
    Akush Ginekol (Mosk); 1995; (5):Suppl: 9 p.. PubMed ID: 8579193
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
    George S; Feng Y; Manola J; Nucci MR; Butrynski JE; Morgan JA; Ramaiya N; Quek R; Penson RT; Wagner AJ; Harmon D; Demetri GD; Krasner C
    Cancer; 2014 Mar; 120(5):738-43. PubMed ID: 24222211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of symptomatic uterine leiomyoma with letrozole.
    Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
    Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of recurrent implantation failure by gonadotropin-releasing hormone agonist and aromatase inhibitor suppression, in women without evidence of endometriosis.
    Khayat S; Elliott B; Dahan MH
    Gynecol Endocrinol; 2019 Mar; 35(3):267-270. PubMed ID: 30328740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
    Sayyah-Melli M; Mobasseri M; Gharabaghi PM; Ouladsahebmadarek E; Rahmani V
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():257-264. PubMed ID: 28076829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
    Ailawadi RK; Jobanputra S; Kataria M; Gurates B; Bulun SE
    Fertil Steril; 2004 Feb; 81(2):290-6. PubMed ID: 14967362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.